Differences in hypothalamic type 2 deiodinase ubiquitination explain localized sensitivity to thyroxine
Open accessThe DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Abstract
The current treatment for patients with hypothyroidism is levothyroxine (L-T4) along with normalization of serum thyroid-stimulating hormone (TSH). However, normalization of serum TSH with L-T4 monotherapy results in relatively low serum 3,5,3'-triiodothyronine (T3) and high serum thyroxine/T3 (T4/T3) ratio. In the hypothalamus-pituitary dyad as well as the rest of the brain, the majority of T3 present is generated locally by T4 deiodination via the type 2 deiodinase (D2); this pathway is self-limited by ubiquitination of D2 by the ubiquitin ligase WSB-1. Here, we determined that tissue-specific differences in D2 ubiquitination account for the high T4/T3 serum ratio in adult thyroidectomized (Tx) rats chronically implanted with subcutaneous L-T4 pellets. While L-T4 administration decreased whole-body D2-dependent T4 conversion to T3, D2 activity in the hypothalamus was only minimally affected by L-T4. In vivo studies in mice harboring an astrocyte-specific Wsb1 deletion as well as in vitro analysis of D2 ubiquitination driven by different tissue extracts indicated that D2 ubiquitination in the hypothalamus is relatively less. As a result, in contrast to other D2-expressing tissues, the hypothalamus is wired to have increased sensitivity to T4. These studies reveal that tissue-specific differences in D2 ubiquitination are an inherent property of the TRH/TSH feedback mechanism and indicate that only constant delivery of L-T4 and L-T3 fully normalizes T3-dependent metabolic markers and gene expression profiles in Tx rats.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The regulation varies by tissue as the brain predominantly expresses type 2 deiodinase, whereas type 1 deiodinase is abundant in other tissues of the body, and by thyroid state, as T3 excess upregulates type 1 deiodinase but downregulates type 2 deiodinase, which is upregulated in hypothyroidism (57–64).”
From Homeostatic control of the thyroid-pituitary axis: perspectives for diagnosis and treatment (2015) · cites this paper as [64]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The regulation varies by tissue as the brain predominantly expresses type 2 deiodinase, whereas type 1 deiodinase is abundant in other tissues of the body, and by thyroid state, as T3 excess upregulates type 1 deiodinase but downregulates type 2 deiodinase, which is upregulated in hypothyroidism (57–64).”
From Homeostatic control of the thyroid-pituitary axis: perspectives for diagnosis and treatment (2015) · cites this paper as [64]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Levothyroxine-treated hypothyroidism is also associated with reduced tri-iodothyronine signalling in the liver and brain.176”
From Hypothyroidism (2024) · cites this paper as [176]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Also in pituitary thyrotrophs, the loss of D2 activity caused by T4 is a much slower process [5].”
From Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Finally, there is a new understanding that, under certain conditions, T3 signaling may be compromised in a tissue-specific fashion while systemic thyroid function is preserved.”
From Emerging Therapies in Hypothyroidism (2024) · cites this paper as [25]
Experimental — accuracy not yet measured
22 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., & Larsen, P. R. (2002) · Endocrine Reviews · doi:10.1210/edrv.23.1.0455 · Cited by 1,853
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber, K. A. (2012) · Endocrine Practice · doi:10.4158/ep12280.gl · Cited by 1,567
Garber, J. R., Cobin, R. H., Gharib, H., Hennessey, J. V., Klein, I., Mechanick, J. I., Pessah-Pollack, R., Singer, P. A., & Woeber for the American Association, K. A. (2012) · Thyroid · doi:10.1089/thy.2012.0205 · Cited by 1,053
Cellular and Molecular Basis of Deiodinase-Regulated Thyroid Hormone Signaling1
Gereben, B., Zavacki, A. M., Ribich, S., Kim, B. W., Huang, S. A., Simonides, W. S., Zeöld, A., & Bianco, A. C. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0019 · Cited by 891
Self-citationhGFAP‐cre transgenic mice for manipulation of glial and neuronal function in vivo
Zhuo, L., Theis, M., Alvarez‐Maya, I., Brenner, M., Willecke, K., & Messing, A. (2001) · genesis · doi:10.1002/gene.10008 · Cited by 659
Bacteriophage P1 site-specific recombination
Sternberg, N., & Hamilton, D. (1981) · Journal of Molecular Biology · doi:10.1016/0022-2836(81)90375-2 · Cited by 579
Ciechanover, A., Heller, H., Elias, S., Haas, A. L., & Hershko, A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1365 · Cited by 562
2012 ETA Guidelines: The Use of L-T4 + L-T3 in the Treatment of Hypothyroidism
Wiersinga, W. M., Duntas, L., Fadeyev, V., Nygaard, B., & Vanderpump, M. P. J. (2012) · European Thyroid Journal · doi:10.1159/000339444 · Cited by 437
Treatment Guidelines for Patients With Hyperthyroidism and Hypothyroidism
Singer, P. A. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520340064038 · Cited by 427
The type 2 iodothyronine deiodinase is expressed primarily in glial cells in the neonatal rat brain
Guadaño-Ferraz, A., Obregón, M. J., Germain, D. L. S., & Bernal, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10391 · Cited by 372
CRANTZ, F. R., SILVA, J. E., & LARSEN, P. R. (1982) · Endocrinology · doi:10.1210/endo-110-2-367 · Cited by 340
Panicker, V., Saravanan, P., Vaidya, B., Evans, J., Hattersley, A. T., Frayling, T. M., & Dayan, C. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1301 · Cited by 327
Abremski, K., & Hoess, R. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43437-5 · Cited by 324
Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients
Gullo, D., Latina, A., Frasca, F., Le Moli, R., Pellegriti, G., & Vigneri, R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022552 · Cited by 307 · cited 1×
“This scenario is partially supported by 2 factors: First, serum T3 is below the lower limit of the reference range in approximately 15% of the hypothyroid patients treated with L-T4 monotherapy, despite normal serum levels of TSH and a relatively higher serum free T4 (6, 7).”
Tu, H. M., Kim, S.-W., Salvatore, D., Bartha, T., Legradi, G., Larsen, P. R., & Lechan, R. M. (1997) · Endocrinology · doi:10.1210/endo.138.8.5318 · Cited by 302 · cited 2×
“In the brain, D2 is expressed in astrocytes (13, 14), while thyroid hormone receptors and type 3 deiodinase (D3), which inactivates T3, are found in neurons (15).”
Grozinsky-Glasberg, S., Fraser, A., Nahshoni, E., Weizman, A., & Leibovici, L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0448 · Cited by 296
Escobar-Morreale, H. F., Obregón, M. J., Escobar del Rey, F., & Morreale de Escobar, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118353 · Cited by 287
Escobar-Morreale, H. F., del Rey, F. E., Obregón, M. J., & de Escobar, G. M. (1996) · Endocrinology · doi:10.1210/endo.137.6.8641203 · Cited by 261
SINGER, P. A. (1995) · JAMA · doi:10.1001/jama.273.10.808 · Cited by 235
Dentice, M., Bandyopadhyay, A., Gereben, B., Callebaut, I., Christoffolete, M. A., Kim, B. W., Nissim, S., Mornon, J.-P., Zavacki, A. M., Zeöld, A., et al. (2005) · Nature Cell Biology · doi:10.1038/ncb1272 · Cited by 227
Self-citationMechanism of strand cleavage and exchange in the Cre-lox site-specific recombination system
Hoess, R. H., & Abremski, K. (1985) · Journal of Molecular Biology · doi:10.1016/0022-2836(85)90224-4 · Cited by 224
Mentuccia, D., Proietti-Pannunzi, L., Tanner, K., Bacci, V., Pollin, T. I., Poehlman, E. T., Shuldiner, A. R., & Celi, F. S. (2002) · Diabetes · doi:10.2337/diabetes.51.3.880 · Cited by 205
Bianco, A. C., Anderson, G., Forrest, D., Galton, V. A., Gereben, B., Kim, B. W., Kopp, P. A., Liao, X. H., Obregon, M. J., Peeters, R. P., et al. (2014) · Thyroid · doi:10.1089/thy.2013.0109 · Cited by 205
Self-citationTu, H. M., Légrádi, G., Bartha, T., Salvatore, D., Lechan, R. M., & Larsen, P. R. (1999) · Endocrinology · doi:10.1210/en.140.2.784 · Cited by 198
Self-citationReplacement Dosage of L-Thyroxine in Hypothyroidism: A Re-Evaluation
Stock, J. M., Surks, M. I., & Oppenheimer, J. H. (1974) · New England Journal of Medicine · doi:10.1056/nejm197403072901001 · Cited by 184
Galton, V. A., Schneider, M. J., Clark, A. S., & St. Germain, D. L. (2009) · Endocrinology · doi:10.1210/en.2008-1572 · Cited by 181
The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration
Dentice, M., Marsili, A., Ambrosio, R., Guardiola, O., Sibilio, A., Paik, J.-H., Minchiotti, G., DePinho, R. A., Fenzi, G., Larsen, P. R., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43670 · Cited by 174
Gereben, B., Goncalves, C., Harney, J. W., Larsen, P. R., & Bianco, A. C. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.11.0558 · Cited by 161
Self-citationFreitas, B. C. G., Gereben, B., Castillo, M., Kalló, I., Zeöld, A., Egri, P., Liposits, Z., Zavacki, A. M., Maciel, R. M. B., Jo, S., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41977 · Cited by 160
Self-citationCoordination of hypothalamic and pituitary T3 production regulates TSH expression
Fonseca, T. L., Correa-Medina, M., Campos, M. P. O., Wittmann, G., Werneck-de-Castro, J. P., Arrojo e Drigo, R., Mora-Garzon, M., Ueta, C. B., Caicedo, A., Fekete, C., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci61231 · Cited by 155
Self-citationOptimal bone strength and mineralization requires the type 2 iodothyronine deiodinase in osteoblasts
Bassett, J. H. D., Boyde, A., Howell, P. G. T., Bassett, R. H., Galliford, T. M., Archanco, M., Evans, H., Lawson, M. A., Croucher, P., St. Germain, D. L., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911346107 · Cited by 147
Castillo, M., Hall, J. A., Correa-Medina, M., Ueta, C., Won Kang, H., Cohen, D. E., & Bianco, A. C. (2011) · Diabetes · doi:10.2337/db10-0758 · Cited by 138
Self-citationDiano, S., Naftolin, F., Goglia, F., & Horvath, T. L. (1998) · Endocrinology · doi:10.1210/endo.139.6.6062 · Cited by 135
Curcio-Morelli, C., Zavacki, A. M., Christofollete, M., Gereben, B., de Freitas, B. C. G., Harney, J. W., Li, Z., Wu, G., & Bianco, A. C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18348 · Cited by 134
Self-citationIto, M., Miyauchi, A., Morita, S., Kudo, T., Nishihara, E., Kihara, M., Takamura, Y., Ito, Y., Kobayashi, K., Miya, A., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-11-1029 · Cited by 133
Panicker, V., Evans, J., Bjøro, T., Åsvold, B. O., Dayan, C. M., & Bjerkeset, O. (2009) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03521.x · Cited by 121
Christoffolete, M. A., Ribeiro, R., Singru, P., Fekete, C., da Silva, W. S., Gordon, D. F., Huang, S. A., Crescenzi, A., Harney, J. W., Ridgway, E. C., et al. (2006) · Endocrinology · doi:10.1210/en.2005-1300 · Cited by 118
Self-citationNovel insights into thyroid hormones from the study of common genetic variation
Dayan, C. M., & Panicker, V. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.19 · Cited by 110 · cited 1×
“A large study also considered the DIO2 polymorphism but only found a weak statistical association with preference for the combination therapy versus monotherapy among hypothyroid patients (33, 34).”
Sagar, G. D. V., Gereben, B., Callebaut, I., Mornon, J.-P., Zeöld, A., da Silva, W. S., Luongo, C., Dentice, M., Tente, S. M., Freitas, B. C. G., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00283-07 · Cited by 103
Self-citationBIANCO, A. C., & SILVA, J. E. (1987) · Endocrinology · doi:10.1210/endo-120-1-55 · Cited by 102
Self-citationCold exposure rapidly induces virtual saturation of brown adipose tissue nuclear T3 receptors
Bianco, A. C., & Silva, J. E. (1988) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1988.255.4.e496 · Cited by 99
Self-citationCARVALHO, S. D., KIMURA, E. T., BIANCO, A. C., & SILVA, J. E. (1991) · Endocrinology · doi:10.1210/endo-128-4-2149 · Cited by 93
Self-citationThe E3 Ubiquitin Ligase TEB4 Mediates Degradation of Type 2 Iodothyronine Deiodinase
Zavacki, A. M., Arrojo e Drigo, R., Freitas, B. C. G., Chung, M., Harney, J. W., Egri, P., Wittmann, G., Fekete, C., Gereben, B., & Bianco, A. C. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01498-08 · Cited by 84
Self-citationRegional physiological adaptation of the central nervous system deiodinases to iodine deficiency
Peeters, R., Fekete, C., Goncalves, C., Legradi, G., Tu, H. M., Harney, J. W., Bianco, A. C., Lechan, R. M., & Larsen, P. R. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.1.e54 · Cited by 79
Self-citationHernandez, A., Morte, B., Belinchón, M. M., Ceballos, A., & Bernal, J. (2012) · Endocrinology · doi:10.1210/en.2011-1905 · Cited by 76
In Vivo Dimerization of Types 1, 2, and 3 Iodothyronine Selenodeiodinases
Curcio-Morelli, C., Gereben, B., Zavacki, A. M., Kim, B. W., Huang, S., Harney, J. W., Larsen, P. R., & Bianco, A. C. (2003) · Endocrinology · doi:10.1210/en.2002-220960 · Cited by 76
Self-citationKádár, A., Sánchez, E., Wittmann, G., Singru, P. S., Füzesi, T., Marsili, A., Larsen, P. R., Liposits, Z., Lechan, R. M., & Fekete, C. (2010) · Journal of Comparative Neurology · doi:10.1002/cne.22432 · Cited by 66
Self-citationEffects of hyper- and hypothyroidism on thyroid hormone concentrations in regions of the rat brain
Broedel, O., Eravci, M., Fuxius, S., Smolarz, T., Jeitner, A., Grau, H., Stoltenburg-Didinger, G., Plueckhan, H., Meinhold, H., & Baumgartner, A. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00043.2003 · Cited by 63 · cited 1×
“The first shows that systemic infusion of high doses of T4 into hypothyroid animals increases tissue and nuclear T3 in the hypothalamus rather than maintaining normal T3 levels (45).”
A sensitive colorimetric assay for mitochondrial α-glycerophosphate dehydrogenase
Gardner, R. S. (1974) · Analytical Biochemistry · doi:10.1016/0003-2697(74)90033-5 · Cited by 59
Kim, B. W., Zavacki, A. M., Curcio-Morelli, C., Dentice, M., Harney, J. W., Larsen, P. R., & Bianco, A. C. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0082 · Cited by 59
Self-citationObumselu, B., & Okigbo, C. (2011) · Cited by 58
Botero, D., Gereben, B., Goncalves, C., de Jesus, L. A., Harney, J. W., & Bianco, A. C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0135 · Cited by 57
Self-citationZeöld, A., Pormüller, L., Dentice, M., Harney, J. W., Curcio‐Morelli, C., Tente, S. M., Bianco, A. C., & Gereben, B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604728200 · Cited by 48
Self-citationHormonal regulation of malic enzyme and glucose-6-phosphate dehydrogenase in brown adipose tissue
Carvalho, S. D., Negrao, N., & Bianco, A. C. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.6.e874 · Cited by 35
Self-citationTSH may not be a good marker for adequate thyroid hormone replacement therapy
Alevizaki, M., Mantzou, E., Cimponeriu, A. T., Alevizaki, C. C., & Koutras, D. A. (2005) · Wiener klinische Wochenschrift · doi:10.1007/s00508-005-0421-0 · Cited by 34
Fekete, C., Freitas, B. C. G., Zeöld, A., Wittmann, G., Kádár, A., Liposits, Z., Christoffolete, M. A., Singru, P., Lechan, R. M., Bianco, A. C., et al. (2007) · Endocrinology · doi:10.1210/en.2007-0448 · Cited by 33 · cited 5×
“In this respect, a major difference between tanycytes and astrocytes with respect to the posttranslational processing of D2 is that only tanycytes express the D2-interacting DUB USP-33 (35).”
InfluentialSelf-citationThyroid Hormone Replacement Therapy: Three Simple Questions, Complex Answers
Bianco, A. C., & Casula, S. (2012) · European Thyroid Journal · doi:10.1159/000339447 · Cited by 32
Self-citationThe Type II Deiodinase Is Retrotranslocated to the Cytoplasm and Proteasomes via p97/Atx3 Complex
Arrojo e Drigo, R., Egri, P., Jo, S., Gereben, B., & Bianco, A. C. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1281 · Cited by 24
Self-citationRamadan, W., Marsili, A., Huang, S. A., Larsen, P. R., & Silva, J. E. (2011) · Endocrinology · doi:10.1210/en.2011-0137 · Cited by 17
Serrano-Lozano, A., Montiel, M., Morell, M., & Morata, P. (1993) · Brain Research Bulletin · doi:10.1016/0361-9230(93)90090-x · Cited by 16
Research works printed but not linked: 3
- Bianco, 1988, Am J Physiol., 255, E496
- Tu, 1999, Endocrinology., 140, 784, 10.1210/endo.140.2.6486 · doi:10.1210/endo.140.2.6486 · Paper page
- Carvalho, 1993, Am J Physiol., 264, E874
Cited by
Chaker, L., Bianco, A. C., Jonklaas, J., & Peeters, R. P. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30703-1 · Cited by 1,159
Self-citationRole of Thyroid Hormones in Skeletal Development and Bone Maintenance
Bassett, J. H. D., & Williams, G. R. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1106 · Cited by 540
Deiodinases and their intricate role in thyroid hormone homeostasis
Luongo, C., Dentice, M., & Salvatore, D. (2019) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0218-2 · Cited by 332
Paradigms of dynamic control of thyroid hormone signaling
Bianco, A. C., Dumitrescu, A., Gereben, B., Ribeiro, M. O., Fonseca, T. L., Fernandes, G. W., & Bocco, B. M. L. C. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00275 · Cited by 293
Self-citationNew insights into thyroid hormone action
Mendoza, A., & Hollenberg, A. N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.012 · Cited by 281
“Within the brain, the hypothalamus D2 activity is not sensitive to T4, whereas the hippocampus and cortex showed increased D2 activity in astrocyte-specific WSB-1-KO mice (Werneck-de-Castro et al., 2015).”
Metadata
- Authors
- Werneck de Castro, J. P., Fonseca, T. L., Ueta, C. B., McAninch, E. A., Abdalla, S., Wittmann, G., Lechan, R. M., Gereben, B., & Bianco, A. C.
- Affiliations
- Rush University Medical Center (US)
- University of Miami (US)
- Tufts University (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2015-01-02
- Volume
- 125
- Issue
- 2
- Pages
- 769-781
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC4319436
- OpenAlex
- W2134856350
- Cited by
- 184
- References
- 62
- Citations by year
- 2026: 11 · 2025: 21 · 2024: 11 · 2023: 14 · 2022: 20 · 2021: 20 · 2020: 16 · 2019: 19 · 2018: 16 · 2017: 15 · 2016: 14 · 2015: 6
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK077148)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Cancer Diagnosis and Treatment
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Keywords
- type 2 deiodinase, hypothalamus, triiodothyronine, T4/T3 ratio, levothyroxine, thyroidectomy, astrocytes, hypothyroidism treatment
- MeSH terms
- Iodothyronine Deiodinase Type II, Animals, Humans, Hypothalamo-Hypophyseal System, Hypothyroidism, Iodide Peroxidase, Thyrotropin, Thyroxine, Gene Expression Regulation, Enzymologic, Gene Deletion, Mice, Knockout, Ubiquitin-Protein Ligases, Intracellular Signaling Peptides and Proteins, Mice, Rats, Ubiquitination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.